Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Urinary Bladder Neoplasms 9Uterine Cervical Dysplasia 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

GX-188 vaccine 4human papillomavirus vaccine, L1 type 16, 18 3Human Papillomavirus DNA Tests 3Colposcopy 3Blood Specimen Collection 3Vaccines 2VGX-3100 2Topotecan 2Restraint, Physical 2Paclitaxel 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Cisplatin 2Biopsy 25-aminolevulinic acid hexyl ester 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2terameprocol 1poly(gamma-glutamic acid) 1poly ICLC 1methyl 5-aminolevulinate 1epigallocatechin gallate 1artesunic acid 1artemisinin 1ZYC101a 1Watchful Waiting 1Vaccines, Synthetic 1Transurethral Resection of Prostate 1Pregnancy Tests 1Pemetrexed 1Papillomavirus Vaccines 1Ointments 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Uterine Cervical Dysplasia × 5-aminolevulinic acid hexyl ester × Clear all
NCT00708942 2013-04-24

Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1

Photocure

Phase 2 Terminated
83 enrolled 14 charts
Gynecologic

Uterine Cervical Dysplasia

NCT00369018 2010-11-30

A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.

Photocure

Phase 1/2 Completed
96 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡